A study of serum CASA and CA 125 levels in patients with ovarian carcinoma.
The assays of Cancer Associated Serum Antigen (CASA) and CA 125 were assessed in the management of patients with ovarian cancer. It was shown that CASA is sensitive to ovarian carcinoma, and both CASA and CA 125 are more useful when used in conjunction.
Meisel
M
M
Department of Gynecology and Obstetrics, Ernst Moritz Arndt University, Greifswald, Germany.
Straube
W
W
Weise
J
J
Burkhardt
B
B
D000328:Adult; D000368:Aged; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D018394:CA-125 Antigen / Q000097:blood; D002277:Carcinoma / Q000097:blood / Q000276:immunology* / Q000601:surgery; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000097:blood / Q000276:immunology* / Q000601:surgery; D011379:Prognosis; D012189:Retrospective Studies; D012680:Sensitivity and Specificity; D016896:Treatment Outcome
D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D018394:CA-125 Antigen